Carregant...
Trial Watch: Proteasomal inhibitors for anticancer therapy
The so-called “ubiquitin-proteasome system” (UPS) is a multicomponent molecular apparatus that catalyzes the covalent attachment of several copies of the small protein ubiquitin to other proteins that are generally (but not always) destined to proteasomal degradation. This enzymatic cascade is cruci...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4904962/ https://ncbi.nlm.nih.gov/pubmed/27308423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723556.2014.974463 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|